New blood test assists oncologists with tumour treatment opt
CellMax Life, a precision cancer blood-testing company, on Wednesday announced the availability of CellMax-LBx Liquid Biopsy in India.

CellMax-LBx is a cancer blood test that analyses circulating tumour DNA (ctDNA). The assay provides oncologists with a valuable tool in managing their patients’ cancer treatments, monitoring treatment response, and assessing the risk of recurrence, according to a statement.

CellMax-LBx is intended as a supplement to a tissue biopsy, and as an alternative when tissue biopsy is not possible. The test profiles 73 genes from circulating tumour DNA (ctDNA) to identify and assess actionable genomic alterations using CellMax Life’s single-molecule-sequencing SMSEQ platform...